Which Weight Management Treatment Suits Your Lifestyle?
Online Prescription Process: Manjaro vs Wegovy Assessment
The online prescription process for both Manjaro and Wegovy follows identical clinical standards at EverydayMeds. Your 3-minute assessment covers essential medical history, current medications, BMI calculation, and contraindication screening—regardless of which treatment you're considering. Licensed UK prescribers review every case individually, ensuring both Manjaro and Wegovy prescriptions meet MHRA safety requirements and NICE guidance.
What sets the Manjaro vs Wegovy decision apart during assessment is the specific health profile evaluation. Wegovy's established clinical data through the STEP trials provides extensive evidence for GLP-1 receptor agonist effectiveness, whilst Manjaro's dual GIP and GLP-1 mechanism offers a different therapeutic approach. Your prescriber considers factors like previous weight management attempts, medical history, and lifestyle preferences when determining suitability for either treatment during the online consultation process.
Manjaro vs Wegovy Pricing: Complete UK Cost Comparison
Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose (£209.99). Our Getting Started bundles provide convenient dose progression options, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, whilst the Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99. New customers apply discount code FIRST40 at checkout, with returning customers using DOSE25.
Manjaro pricing follows a different structure given its distinct dosing schedule and dual-action mechanism. When comparing Manjaro vs Wegovy costs, consider the complete treatment pathway rather than individual pen prices—both treatments require dose escalation and long-term commitment for optimal weight management results. Bundle options provide supply security and reduce ordering frequency, though the choice between Manjaro vs Wegovy should primarily focus on clinical suitability rather than cost alone.
Clinical Evidence: Manjaro vs Wegovy Trial Data
Wegovy's clinical foundation rests on the comprehensive STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, when used alongside diet and exercise modifications. The recent SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events (HR 0.80), establishing Wegovy's broader health benefits beyond weight management.
Manjaro vs Wegovy head-to-head comparisons require careful interpretation, as different trial designs, populations, and endpoints make direct percentage comparisons inappropriate. Both treatments represent prescription-only medicines with robust clinical development programmes, though Wegovy's longer market presence provides more extensive real-world safety and effectiveness data for UK prescribers to consider during patient consultations.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1 produced in your intestines after eating. This mechanism reduces appetite by acting on brain appetite centres, promoting feelings of fullness after smaller meals, and may help reduce food cravings throughout the day. The once-weekly FlexTouch pen delivers precise dosing through subcutaneous injection, with gradual dose escalation over 16 weeks to reach the 2.4mg maintenance level. Unlike Manjaro's dual GIP and GLP-1 approach, Wegovy focuses specifically on GLP-1 pathway activation for weight management support.
Complete Ordering Process: Manjaro vs Wegovy Prescriptions
Both Manjaro and Wegovy prescriptions begin with our 3-minute online clinical assessment, covering medical history, current medications, weight management goals, and contraindication screening. Licensed UK prescribers review applications within 3 working days (24-hour express service available), ensuring clinical appropriateness for either treatment option. Once approved, next-day delivery uses specialised cold-chain packaging to maintain medication integrity during transport. Your prescription includes comprehensive dosing instructions, injection technique guidance, and ongoing clinical support throughout treatment. GPhC registration #9012878 ensures genuine medication supply from our UK-licensed pharmacy.
Storage and Practical Considerations: Manjaro vs Wegovy
Wegovy storage requirements include refrigeration at 2-8°C before first use, with a significant practical advantage of remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from the fridge. This 6-week room temperature stability surpasses Manjaro's 21-day limit, making Wegovy more suitable for frequent travellers or those with limited refrigeration access. Both treatments use pre-filled injection pens with different mechanisms—Wegovy's FlexTouch system versus Manjaro's pen design—though injection frequency remains weekly for both options. Dose escalation schedules differ between treatments, with Wegovy following a structured 16-week progression to maintenance levels.
Online Prescription Advantages: Why Choose Digital Assessment for Manjaro vs Wegovy
Digital prescription services eliminate traditional barriers when comparing Manjaro vs Wegovy options, removing the need for multiple GP appointments to discuss different treatments. Our online platform allows detailed comparison of both medications' profiles, dosing schedules, and suitability factors before commitment. Licensed prescribers provide expert guidance on Manjaro vs Wegovy selection based on your specific health profile, previous treatment responses, and lifestyle requirements.
The 3-minute assessment process streamlines access to both treatments whilst maintaining clinical rigour—prescribers spend adequate time reviewing each application regardless of whether you're seeking Manjaro or Wegovy. This digital approach particularly benefits patients who've researched both options and want professional medical guidance on the most appropriate choice for their weight management journey.
Making Your Choice: Manjaro vs Wegovy Prescription Support
Both Manjaro and Wegovy represent evidence-based approaches to weight management, each requiring prescription-only access and professional medical oversight. EverydayMeds provides equal access to both treatments through our streamlined online prescription service, ensuring you receive appropriate clinical assessment regardless of your initial preference. Licensed prescribers consider individual factors including medical history, lifestyle requirements, and treatment goals when guiding Manjaro vs Wegovy decisions. Apply discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout, and begin your assessment at https://everydaymeds.co.uk/collections/wegovy to explore both treatment options. Our clinical team provides ongoing support throughout your weight management journey, ensuring optimal outcomes with whichever prescription-only medicine proves most suitable for your needs.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
